Hong Kong Short Reporting - Insights from 28 June Data
We analyse the latest SFC data released today on short position reporting in Hong Kong for the week ended 28 June.Total short notional in Hong Kong...
649 Views
Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs
Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...
830 Views
Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation
Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...
914 Views
Luye Pharma Group Ltd (2186 HK) - Innovative R&D
Luye’s existing drugs seem to have entered a mature stage with slower growth prospects going ahead. However the oncology segment, which represents...
385 Views
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...
3.5k Views